This is a non-core endpoint: only basic statistics are computed.
Exposure to other and unspecified forces of nature
VWXY20_EXPOS_OTHER_UNSPE_FORCES_NATURE
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
223 |
4. Check minimum number of eventsNone |
223 |
5. Include endpointsNone |
223 |
6. Filter based on genotype QC (FinnGen only) |
213 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 5
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- X30-X39
Similar endpoints
↥List of similar endpoints to
Exposure to other and unspecified forces of nature
based on the number of shared cases.
Similar with more cases:
- Other external causes of accidental injury
- Accidents
- External causes of morbidity and mortality
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 213 | 122 | 91 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 53.11 | 46.09 | 62.52 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 223
- Matched controls
- 2230
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
X39
ICD-10 Finland
Exposure to other and unspecified forces of nature
+∞
319.6
222
*
T78.4
ICD-10 Finland
Allergy, unspecified
14.4
60.2
62
58
C01CA24
ATC
epinephrine; parenteral
7.4
30.0
50
84
X59
ICD-10 Finland
Exposure to unspecified factor
3.8
18.5
76
267
T78.3
ICD-10 Finland
Angioneurotic oedema
22.0
15.4
22
11
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.6
14.1
55
184
X58
ICD-10 Finland
Exposure to other specified factors
3.4
12.8
55
195
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
14.3
12.7
21
16
Z3226
NOMESCO Finland
Physiotherapist
3.1
11.8
61
241
Z2221
NOMESCO Finland
Medical doctor
2.8
11.5
85
407
R4110
NOMESCO Finland
Physiotherapy
2.7
11.1
82
391
XQ800
NOMESCO Finland
Prick test
4.2
11.0
32
86
XF400
NOMESCO Finland
ECG with 12 standard connections
3.2
10.8
50
184
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.6
10.4
81
396
Z3231
NOMESCO Finland
Registered nurse
2.6
10.2
80
391
ZXA00
NOMESCO Finland
Right side
2.7
10.0
70
323
T68
ICD-10 Finland
Hypothermia
57.6
9.7
11
*
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
3.4
9.5
37
122
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.9
9.1
48
190
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.7
8.1
50
214
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.3
8.0
32
107
K59.09
ICD-10 Finland
Constipation, unspecified
4.0
8.0
24
66
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.4
7.5
67
342
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.2
7.4
32
112
WX892
NOMESCO Finland
Monitored bed care
3.5
7.4
26
80
AA1AD
NOMESCO Finland
CT of head and brain
2.4
7.3
66
337
T34.8
ICD-10 Finland
Frostbite with tissue necrosis of ankle and foot
+∞
7.3
7
*
X50
ICD-10 Finland
Overexertion and strenuous or repetitive movements
12.6
7.2
12
10
N05AX12
ATC
aripiprazole; systemic
4.5
7.2
18
43
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
7.0
68
359
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
11.4
6.9
12
11
WX402
NOMESCO Finland
General anaesthesia
2.4
6.8
56
274
H02AB06
ATC
prednisolone; systemic
2.1
6.6
111
722
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.6
6.3
21
62
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
6.3
90
549
X31
ICD-10 Finland
Exposure to excessive natural cold
27.5
6.3
8
*
Z71.8
ICD-10 Finland
Other specified counselling
2.1
6.1
82
487
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
6.4
6.1
15
25
Z51.6
ICD-10 Finland
Desensitization to allergens
10.4
6.1
11
11
R05
ICD-10 Finland
Cough
2.3
6.1
57
294
N05CF01
ATC
zopiclone; oral
2.1
6.0
74
425
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
6.0
57
295
Z2446
NOMESCO Finland
Social worker
3.2
6.0
24
80
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
74
316
3.01
12.56
3.7
3.4
208.40
236.83
ng/l
0.10
45
224
16
9
19.01
10.90
1.4
1.1
0.31
0.28
g/l
—
16
9
66
284
2.88
10.87
4.1
2.7
4.33
2.07
e6/l
0.74
32
156
64
292
2.67
9.27
4.0
2.6
0.63
0.84
e6/l
0.39
30
162
46
176
3.03
9.24
16.2
8.2
-0.35
0.95
mmol/l
1.33
35
138
120
743
2.33
8.80
10.9
6.3
1.21
1.21
mmol/l
0.22
114
690
23
60
4.16
8.20
2.8
2.1
—
—
—
0
0
39
151
2.92
7.61
4.9
5.0
0.52
1.52
mmol/l
1.40
32
115
33
116
3.17
7.60
2.0
1.3
159.72
157.03
u/ml
0.02
33
104
42
170
2.81
7.56
3.4
2.5
50.42
34.38
u/l
0.54
33
143
55
260
2.48
7.25
1.9
1.9
—
—
—
0
0
180
1388
2.54
7.19
8.1
7.0
76.31
78.41
u/l
0.40
171
1305
83
474
2.20
7.04
2.9
2.1
978.01
357.44
u/l
0.58
77
451
85
495
2.16
6.82
4.8
2.9
0.34
0.44
e6/l
0.21
57
361
25
80
3.39
6.67
1.8
1.6
—
—
—
0
0
120
811
2.04
6.35
11.7
7.3
1.21
1.21
mmol/l
0.09
114
702
42
188
2.52
6.15
17.4
7.9
105.17
104.49
mmol/l
0.34
42
188
147
1077
2.07
6.13
11.6
9.1
4.44
4.07
e9/l
1.09
123
949
106
693
2.01
6.07
4.6
4.9
34.64
36.00
g/l
1.55
100
661
25
86
3.15
5.95
2.4
1.9
—
—
—
0
0
19
56
3.62
5.73
1.3
1.4
—
—
—
0
0
73
432
2.03
5.41
2.7
2.2
—
—
—
0
0
97
634
1.94
5.40
4.6
3.0
—
—
—
0
0
122
867
1.90
5.22
3.0
2.5
—
—
—
0
0
69
413
1.97
4.89
1.9
1.9
1.87
1.13
mg/l
0.65
47
319
97
654
1.86
4.77
2.4
1.8
95.08
94.10
pmol/l
0.08
58
344
38
184
2.28
4.65
2.1
1.8
—
—
—
0
0
92
614
1.85
4.65
3.3
3.3
27.97
29.61
u/l
0.40
86
585
167
1347
1.95
4.52
5.0
3.9
14.74
10.48
mm/h
2.06
156
1249
27
114
2.56
4.44
1.9
1.5
—
—
—
0
0
38
188
2.23
4.42
2.1
1.8
—
—
—
0
0
67
411
1.90
4.36
2.3
2.0
3.18
3.01
mg/l
0.10
54
361
209
1855
3.02
4.22
24.0
12.7
27.33
22.70
mg/l
1.03
178
1466
74
474
1.84
4.19
1.4
1.3
7.16
2.06
u/ml
0.39
16
129
43
229
2.09
4.15
3.0
2.3
23.03
23.43
%
0.05
37
200
53
307
1.95
4.06
1.7
1.2
26.57
29.06
iu/ml
0.09
15
99
40
213
2.07
3.86
2.2
3.7
10.66
6.93
umol/l
0.42
35
184
71
466
1.77
3.64
1.8
1.6
1.27
1.36
mmol/l
0.55
60
405
61
383
1.82
3.62
1.8
1.5
16.54
21.35
nmol/l
2.22
55
336
134
1051
1.69
3.53
9.9
4.6
6.65
6.54
mmol/l
0.27
128
964
6
6
10.23
3.51
1.0
1.0
77.00
97.83
%
—
6
6
113
849
1.67
3.50
3.2
2.7
95.44
99.32
ug/l
0.12
105
798
50
298
1.87
3.49
1.5
1.3
2.09
10.07
u/ml
—
8
130
213
1944
3.13
3.39
24.9
14.1
76.49
74.63
umol/l
0.26
213
1944
65
428
1.73
3.25
1.7
1.6
—
—
—
0
0
22
98
2.38
3.25
1.7
1.4
—
—
—
0
0
11
29
3.93
3.23
1.2
1.2
—
—
—
0
0
11
29
3.93
3.23
1.2
1.2
—
—
—
0
0
9
20
4.64
3.15
1.0
1.3
—
—
—
0
0
9
20
4.64
3.15
1.0
1.3
—
—
—
0
0
13
41
3.30
3.11
3.1
2.9
35.12
30.02
mg/l
0.24
13
35
13
41
3.30
3.11
3.0
2.9
47.32
213.70
mg/l
0.58
13
35
9
21
4.42
3.03
1.0
1.2
—
—
—
0
0
9
21
4.42
3.03
1.0
1.2
—
—
—
0
0
9
21
4.42
3.03
1.0
1.2
—
—
—
0
0
65
436
1.69
3.02
2.3
2.7
340.22
6134.27
umol/l
1.71
59
385
24
115
2.22
3.01
1.0
1.0
—
—
—
0
0
160
1344
1.67
2.99
4.2
3.5
—
—
—
0
0
190
1677
1.90
2.95
5.3
4.4
1.88
1.82
mu/l
0.11
179
1542
101
763
1.59
2.90
11.6
11.8
1.37
1.20
inr
0.52
18
235
13
48
2.81
2.77
1.7
1.4
219.29
320.65
ug/g
—
7
28
77
551
1.61
2.75
3.4
2.4
73.56
63.12
u/l
0.27
71
519
14
55
2.65
2.67
1.6
1.4
—
—
—
0
0
151
1268
1.59
2.65
3.9
3.2
45.13
45.51
u/l
0.03
142
1215
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
42
2.96
2.59
2.7
2.9
0.57
0.35
u/ml
—
5
24
12
44
2.83
2.59
1.3
1.4
—
49.72
—
0
6
10
32
3.22
2.47
1.7
1.5
—
—
—
0
0
8
22
3.73
2.38
1.0
1.0
—
—
—
0
0
25
135
1.96
2.33
1.4
1.3
—
37.38
—
0
10
159
1372
1.55
2.29
4.2
3.8
14.44
14.60
pmol/l
0.31
150
1248
189
1706
1.71
2.18
21.8
11.2
87.69
86.69
ml/min/173m2
0.20
153
1377
10
37
2.78
2.10
1.3
1.2
4.20
4.17
u/ml
—
5
18
30
179
1.78
2.08
2.2
1.9
—
—
—
0
0
92
721
1.47
2.06
2.7
2.3
69.98
73.57
nmol/l
0.53
85
657
14
63
2.30
2.05
1.3
2.1
—
—
—
0
0
37
238
1.66
1.98
1.8
1.5
1.68
1.40
%
0.87
29
213
6
16
3.82
1.95
1.3
1.5
4.47
8.09
u/l
—
6
16
5
12
4.24
1.83
1.2
1.3
—
—
—
0
0
14
67
2.16
1.80
1.9
1.4
—
—
—
0
0
5
14
3.63
1.62
4.8
2.3
—
—
—
0
0
8
32
2.55
1.61
1.0
1.3
—
—
—
0
0
10
45
2.28
1.48
2.9
3.0
—
—
—
0
0
9
39
2.36
1.45
1.1
1.1
—
—
—
0
0
12
60
2.06
1.41
1.3
1.1
—
—
—
0
0
21
128
1.71
1.39
1.7
2.0
3.13
6.01
ug/l
2.31
15
113
9
42
2.19
1.35
1.2
1.3
—
—
—
0
0
19
115
1.71
1.29
2.5
3.6
4.37
4.74
pmol/l
1.04
19
101
5
18
2.82
1.29
14.8
14.8
1301.60
1589.56
nmol/l
—
5
18
5
18
2.82
1.29
7.0
9.1
752.60
963.33
nmol/l
—
5
18
8
36
2.27
1.25
2.0
1.4
—
—
—
0
0
6
25
2.44
1.25
2.2
1.8
—
—
—
0
0
11
56
2.01
1.24
1.7
1.2
—
—
—
0
0
39
284
1.45
1.24
1.9
1.7
968.55
1172.96
nmol/l
0.77
31
229
43
320
1.43
1.22
2.5
2.4
—
—
—
0
0
5
19
2.67
1.22
1.2
1.3
—
—
—
0
0
6
26
2.34
1.19
1.5
1.7
—
—
—
0
0
8
39
2.09
1.16
1.1
1.2
—
—
—
0
0
5
20
2.53
1.15
1.8
1.2
—
—
—
0
0
5
21
2.41
1.09
1.4
1.0
—
—
—
0
0
75
624
1.30
1.05
5.6
3.3
32.86
32.39
ng/l
0.01
52
382
9
46
2.00
1.05
1.3
1.1
—
—
—
0
0
7
35
2.03
1.01
1.7
1.7
—
—
—
0
0
11
61
1.84
1.00
1.3
1.9
—
—
—
0
0
6
120
0.49
0.96
1.7
4.3
1.20
1.22
mmol/l
—
6
107
10
55
1.86
0.93
1.6
1.2
—
—
—
0
0
58
475
1.30
0.91
5.5
3.9
14.31
8.45
mg/mmol
0.36
44
311
189
1790
1.37
0.90
5.3
4.5
2.69
2.77
mmol/l
0.60
178
1670
16
105
1.56
0.84
1.4
2.3
1110.33
3356.56
u/l
—
7
37
182
1720
1.32
0.83
4.7
4.1
6.01
5.85
mmol/l
0.57
168
1593
6
32
1.90
0.82
1.5
1.6
—
—
—
0
0
8
47
1.73
0.81
1.1
2.6
2.71
5.31
umol/l
—
8
33
59
698
0.79
0.81
3.4
3.4
—
—
—
0
0
186
1765
1.32
0.81
4.7
4.1
4.57
4.64
mmol/l
0.37
178
1656
20
140
1.47
0.80
2.4
1.8
—
—
—
0
0
38
475
0.76
0.80
3.3
3.5
0.00
0.00
estimate
—
10
170
100
887
1.23
0.79
3.6
3.4
0.00
0.01
estimate
0.50
11
188
65
550
1.26
0.79
4.7
3.3
2.34
2.35
mmol/l
0.14
55
488
185
1757
1.31
0.77
4.6
4.0
1.39
1.45
mmol/l
1.21
174
1639
172
1619
1.27
0.77
6.6
5.2
39.71
39.21
mmol/mol
0.27
166
1526
7
40
1.77
0.72
1.0
2.0
—
—
—
0
0
7
41
1.73
0.70
1.1
1.4
—
113.30
—
0
10
5
27
1.87
0.69
1.0
1.1
—
—
—
0
0
99
888
1.21
0.68
5.7
4.7
0.00
0.00
estimate
—
10
175
5
28
1.80
0.66
1.2
1.6
—
—
—
0
0
7
44
1.61
0.65
1.3
1.4
—
—
—
0
0
100
901
1.20
0.65
3.9
3.4
0.00
0.00
estimate
—
9
171
36
291
1.28
0.63
2.3
2.2
—
—
—
0
0
35
282
1.29
0.63
2.3
2.8
2.45
2.44
mmol/l
0.40
26
246
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
0
20
0.00
0.60
0.0
1.8
—
—
—
0
0
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
6
38
1.59
0.54
2.0
2.7
62.33
57.21
%
—
6
38
9
63
1.45
0.53
1.4
3.1
—
—
—
0
0
176
1692
1.19
0.46
4.3
3.7
1.37
1.26
mmol/l
0.75
164
1572
14
104
1.37
0.44
1.3
1.5
—
—
—
0
0
16
123
1.32
0.42
2.1
2.4
73.83
67.70
ml/min/173m2
—
6
54
0
18
0.00
0.40
0.0
4.2
—
97.04
—
0
18
5
35
1.44
0.39
1.2
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.9
—
7.87
—
0
19
16
202
0.78
0.38
1.4
1.6
—
—
—
0
0
13
98
1.35
0.38
1.4
1.4
—
—
—
0
0
13
98
1.35
0.38
1.4
1.4
—
—
—
0
0
13
98
1.35
0.38
1.4
1.4
—
—
—
0
0
13
98
1.35
0.38
1.4
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
2.0
—
40.51
—
0
11
0
11
0.00
0.21
0.0
3.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
38.91
—
0
8
0
14
0.00
0.20
0.0
1.0
—
552.44
—
0
9
6
50
1.21
0.20
1.2
1.4
—
—
—
0
0
14
118
1.20
0.19
1.9
1.3
—
—
—
0
0
7
60
1.17
0.18
1.9
1.5
—
—
—
0
0
5
68
0.73
0.17
1.6
1.6
—
—
—
0
0
50
472
1.08
0.14
5.2
4.4
24.06
21.71
%
0.39
24
222
18
167
1.08
0.07
3.9
4.0
2.99
76.09
ug/l
0.89
18
137
17
160
1.07
0.04
3.0
3.3
—
—
—
0
0
17
164
1.04
0.00
1.5
1.6
—
—
—
0
0
34
339
1.00
0.00
1.6
1.5
—
—
—
0
0
19
193
0.98
0.00
5.7
7.6
—
—
—
0
0
34
338
1.01
0.00
3.0
2.9
0.54
0.75
ug/l
1.53
26
226
19
195
0.97
0.00
4.8
4.1
31.85
30.36
%
0.26
13
131
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
7.4
—
—
—
0
0
8
83
0.96
-0.00
1.8
2.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
6.35
—
0
6
0
9
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: VWXY20_EXPOS_OTHER_UNSPE_FORCES_NATURE – Exposure to other and unspecified forces of nature
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).